<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01935596</url>
  </required_header>
  <id_info>
    <org_study_id>PI09-PR-DUPONT</org_study_id>
    <nct_id>NCT01935596</nct_id>
  </id_info>
  <brief_title>Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%</brief_title>
  <acronym>ROPI-LEVO</acronym>
  <official_title>Comparative Study of the Effects of Two Local Anesthetics Administered Intrathecally: 0.5% Levobupivacaine and Ropivacaine 0.5%</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Biomedical Research, prospective, randomized, double blind, controlled monocentric,
      phase IV comparison of the effects of two local anesthetics intrathecally: 0.5%
      levobupivacaine and ropivacaine 0.5%.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Progress in the practice of anesthesia led to a safety requirement of growing in daily
      practice. Spinal anesthesia commonly used technique for surgery of the lower limbs, provides
      a triple neurological lock (sensory, motor and autonomic) of roots of the spinal cord by
      intrathecal injection of a local anesthetic agent, following the rules of and strict aseptic
      conditions.

      Levobupivacaine and ropivacaine local anesthetic agents are considered less toxic and tend to
      replace the use of bupivacaine, reference molecule, but the plasma transition is extremely
      toxic to patients. However, there is currently no study comparing the benefits of
      levobupivacaine and ropivacaine in isobaric form injected intrathecally for trauma surgery of
      the lower limbs. We propose to conduct a prospective, randomized double-blind comparison of
      the use of these two molecules in spinal isobaric form by evaluating the time and duration of
      action (sensory and motor block), hemodynamic and ventilatory changes (sympathetic block),
      and the occurrence of any adverse events.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>duration of anesthesia on sensitivity</measure>
    <time_frame>during 6h after induction</time_frame>
    <description>Thermo-algesic exploration of sensitivity through the application of an ice cube</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of anesthesia on motor block</measure>
    <time_frame>during 6h after induction</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Patients Undergoing Lower Limb Surgery</condition>
  <arm_group>
    <arm_group_label>ropivacaïne 0,5%,</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal administration of 15mg of ropivacaine 0.5%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lévobupivacaïne 0,5%</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intrathecal administration of 15mg of levobupivacaine 0.5%</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ropivacaïne</intervention_name>
    <description>spinal anesthesia.</description>
    <arm_group_label>ropivacaïne 0,5%,</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lévobupivacaïne</intervention_name>
    <arm_group_label>lévobupivacaïne 0,5%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient admitted to the emergency for lower limb trauma,

          -  age over 18 years and below 65 years

          -  lower limb trauma surgery can be performed under spinal anesthesia.

        Exclusion Criteria:

          -  Refusal of patients to participate in the study,

          -  Patient with cons-indication to spinal anesthesia:

               -  Local anesthetic allergy agents (1/13000)

               -  bleeding disorders, including pharmacological origin

               -  infection at the puncture site,

               -  refusal of spinal anesthesia by the patient,

          -  Patient trust,

          -  Patients whose coagulation is abnormal.

          -  Patients with cognitive impairment or incapacitated adult,

          -  Multiple trauma,

          -  Porphyria,

          -  Central preexisting neuropathy,

          -  A history of spinal surgery,

          -  Epilepsy uncontrolled by treatment,

          -  Hypovolemia,

          -  Pregnant or lactating women,

          -  Participation in another ongoing clinical trial,

          -  Patient on anticoagulant therapy,

          -  Patient not affiliated with a social security system.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hervé DUPONT, Professor</last_name>
    <role>Study Director</role>
    <affiliation>CHU Amiens France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hervé DUPONT</name>
      <address>
        <city>Amiens</city>
        <state>Picardie</state>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 23, 2012</study_first_submitted>
  <study_first_submitted_qc>September 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>May 13, 2016</last_update_submitted>
  <last_update_submitted_qc>May 13, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Randomized study</keyword>
  <keyword>Lower limbs surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

